Topics
Glioblastoma | Treatment | Clinical trials | Overview
Home > Publications > Topics > Glioblastoma > Treatment > Clinical trials > Overview
Fukushima CM, de Groot J.
Updates for
newly diagnosed and recurrent glioblastoma: a review of recent
clinical trials.
Curr
Opin Neurol. 2024 Sep 13. doi:
10.1097/WCO.0000000000001320. PMID:
39258745. Review. ˍ
Lim-Fat MJ, Roberto K, Wen PY.
Clinical
trial design for novel targeted agents in neuro-oncology.
J
Neurooncol. 2024 Oct 8. doi:
10.1007/s11060-024-04846-5. PMID:
39377992. Review˰ ˍ
*Tang J, Karbhari N, Campian JL.
Therapeutic
Targets in Glioblastoma: Molecular Pathways, Emerging Strategies,
and Future Directions.
Cells.
2025 Mar 26;14(7):494. doi:
10.3390/cells14070494. PMID:
40214448. Review. ˍ
Kendall N, Rechberger JS, Hamouda AM, Cwajna M, Ghozy S,
Arumaithurai K, Kallmes DF.
Assessing
compliance to reporting mandates in glioblastoma-related clinical
trials.
PLoS
One. 2025 May 16;20(5):e0323109. doi:
10.1371/journal.pone.0323109. PMID:
40378099. Regulations. ˍ
Sferruzza G, Desingu K, Cubero Cruz A, Finocchiaro G.
Assessing
time-trend bias in glioblastoma prognosis over two decades of
clinical trials.
Neuro
Oncol. 2025 Jun 28:noaf158. doi:
10.1093/neuonc/noaf158. PMID:
40580109. Observational study˰
ˍ
AI
Overview